Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
12.54
-0.43 (-3.32%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Contineum Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 468 | 418 | 378 | - | - | - |
| Market Cap Growth | 338.18% | 10.56% | - | - | - | - |
| Enterprise Value | 214 | 241 | 164 | - | - | - |
| Last Close Price | 12.54 | 11.43 | 14.65 | - | - | - |
| PB Ratio | 1.79 | 1.60 | 1.91 | - | - | - |
| P/TBV Ratio | 1.79 | 1.60 | 1.91 | - | - | - |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.01 | 0.15 | 0.08 |
| Debt / EBITDA Ratio | - | - | - | 0.03 | - | - |
| Debt / FCF Ratio | - | - | - | 0.03 | - | - |
| Net Debt / Equity Ratio | -0.98 | -0.98 | -1.00 | -1.00 | -1.05 | -1.04 |
| Net Debt / EBITDA Ratio | 3.76 | 3.76 | 3.92 | -7.66 | 1.85 | 2.26 |
| Net Debt / FCF Ratio | 4.59 | 4.59 | 5.95 | -6.58 | 2.05 | 2.42 |
| Asset Turnover | - | - | - | 0.55 | - | - |
| Quick Ratio | 26.98 | 26.98 | 20.53 | 22.83 | 6.26 | 18.78 |
| Current Ratio | 27.50 | 27.50 | 20.69 | 23.29 | 6.41 | 18.99 |
| Return on Equity (ROE) | -26.13% | -26.13% | -26.19% | 27.71% | -48.09% | - |
| Return on Assets (ROA) | -17.38% | -17.38% | -18.54% | 11.10% | -23.44% | - |
| Return on Invested Capital (ROIC) | -1375.07% | -2303.96% | - | - | - | - |
| Return on Capital Employed (ROCE) | -25.50% | -25.50% | -25.10% | 12.90% | -52.70% | -42.90% |
| Earnings Yield | -12.81% | -14.37% | -11.19% | - | - | - |
| FCF Yield | -11.86% | -13.30% | -8.83% | - | - | - |
| Buyback Yield / Dilution | -43.14% | -43.14% | -469.95% | -51.38% | -6.35% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.